ACAD vs REGN: Which Stock is Better?

Side-by-side comparison of Acadia Pharmaceuticals Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

ACAD

Acadia Pharmaceuticals Inc

$26.29

REGN

Regeneron Pharmaceuticals Inc

$733.78

Key Metrics Comparison

MetricACADREGNWinner
Market Cap$4.45B$77.69BREGN
P/E Ratio16.9617.57ACAD
EPS (TTM)$1.55$41.71REGN
Revenue Growth0.1%0.0%ACAD
Gross Margin59.0%45.8%ACAD

Analyze ACAD

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ACAD or REGN a better investment?

Comparing ACAD and REGN: Acadia Pharmaceuticals Inc has a market cap of $4.45B while Regeneron Pharmaceuticals Inc has $77.69B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ACAD and REGN?

ACAD (Acadia Pharmaceuticals Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ACAD or REGN?

Based on P/E ratios, ACAD trades at a lower multiple (17.0x vs 17.6x).

Which is growing faster: ACAD or REGN?

ACAD has higher revenue growth at 0.1% vs 0.0% for REGN.

Which company is more profitable: ACAD or REGN?

Acadia Pharmaceuticals Inc (ACAD) has higher gross margins at 59.0% compared to 45.8% for REGN.

Which is the larger company: ACAD or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $77.69B compared to $4.45B for ACAD.

Should I buy ACAD or REGN in 2026?

Both ACAD and REGN have investment merit. ACAD trades at $26.29 while REGN trades at $733.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ACAD and REGN stock?

Key differences: Market Cap ($4.45B vs $77.69B), P/E Ratio (17.0x vs 17.6x), Revenue Growth (0.1% vs 0.0%), Gross Margin (59.0% vs 45.8%).

Popular Stock Comparisons